Robuta

https://phrma.org/blog/new-phrma-report-nearly-200-medicines-in-development-for-heart-disease-stroke-and-other-cardiovascular-diseases
newphrmareportnearlymedicines
https://phrma.org/resources/2021-industry-profile-toolkit-innovative-contracting-opportunities-and-challenges
industry profilecontracting opportunitiestoolkitinnovativechallenges
https://phrma.org/blog/why-the-hepatitis-b-vaccine-matters
hepatitis b vaccinemattersphrma
https://phrma.org/resources/industry-profile-2022
industry profilephrma
https://phrma.org/blog/50-state-poll-says-americans-are-concerned-that-hospital-markups-hurt-patients
statepollsaysamericansconcerned
https://phrma.org/blog/word-of-the-month-long-covid
long covidwordmonthphrma
https://phrma.org/blog/clinical-trials-qanda-improving-the-recruitment-process-by-listening-to-patients
clinical trialsrecruitment processqimprovinglistening
https://www.commondreams.org/views/2009/08/09/democrats-pay-play-deal-phrma
The NYT is reporting that PhRMA will spend $150 million in advertising to support the White House health care plan in August: The drug industry has already...
opiniondemocratspayplaydeal
https://phrma.org/blog/new-non-discrimination-rule-neglects-to-define-discriminatory-benefits
non discriminationnewruledefinediscriminatory
https://phrma.org/blog/witnessing-a-historic-moment-in-u-s-japan-relations
witnessinghistoricmomentujapan
https://phrma.org/resources/statement-prescription-drug-user-fee-act-reauthorization
prescription druguser feestatementactreauthorization
https://phrma.org/blog/direct-purchase-programs-can-lower-costs-for-patients
direct purchase programslower costspatientsphrma
https://phrma.org/blog/what-is-inter-partes-review-and-why-does-it-matter
inter partes reviewmatter
https://phrma.org/resources/washington-share-the-savings-one-pager
one pagerwashingtonsharesavingsphrma
https://phrma.org/blog/2020-fda-approvals-show-innovation-despite-covid-19-pandemic-challenges
fda approvalsshowinnovationdespitecovid
https://phrma.org/blog/icymi-regulators-urge-broader-health-networks
icymiregulatorsurgehealthnetworks
https://phrma.org/blog/8-reasons-to-celebrate-world-kidney-day
world kidney dayreasonscelebratephrma
https://phrma.org/resources/phrma-statement-on-the-war-in-ukraine
phrmastatementwarukraine
https://phrma.org/resources/value-assessments-should-include-all-the-outcomes-that-matter-to-patients-and-families
valueassessmentsincludeoutcomesmatter
https://phrma.org/resources/what-is-pdufa-vi
pdufaviphrma
https://phrma.org/resources/modern-healthcare-leadership-symposium
modern healthcareleadership symposiumphrma
https://phrma.org/blog/by-the-numbers-340b-continues-to-climb-in-profits-dwindle-with-patient-support
numberscontinuesclimbprofitsdwindle
https://phrma.org/resources
resourcesphrma
https://phrma.org/blog/guest-post-phrma-talks-racial-and-health-equity-with-stephanie-dyson-head-of-office-at-biogen
guest posthealth equityphrmatalksracial
https://phrma.org/resources/applying-icer-assessments-alaska-fact-sheet
fact sheetapplyingicerassessmentsalaska
https://phrma.org/blog/how-drug-importation-schemes-could-increase-u-s-law-enforcement-burdens
drug importationlaw enforcementschemescouldincrease
https://phrma.org/blog/post-approval-r-and-d-is-critical-for-fighting-cancer-the-ira-makes-it-more-difficult
fighting cancerpostapprovalcritical
https://phrma.org/blog/340b-spotlight-340b-hospitals-account-for-majority-of-part-b-reimbursements
part bspotlighthospitalsaccountmajority
https://phrma.org/blog/no-matter-how-you-structure-it-government-arbitration-is-wrong-for-medicare-drug-coverage
matterstructuregovernmentarbitrationwrong
https://phrma.org/resources/phrma-statement-on-help-act
phrmastatementhelpact
https://phrma.org/resources/research-in-texas
researchtexasphrma
https://phrma.org/policy-issues/innovative-medicines/vaccines
vaccinesphrma
https://phrma.org/resources/state-map/maryland
marylandphrma
https://phrma.org/blog/fact-check-friday-the-truth-about-ipab
fact checkfridaytruthipabphrma
https://phrma.org/resources/health-coverage-hurdles
health coveragehurdlesphrma
https://phrma.org/blog/340b-spotlight-audit-findings-show-importance-of-increased-oversight-of-340b-program
audit findingsspotlightshowimportanceincreased
https://phrma.org/blog/gao-again-recommends-improvements-to-340b-program
gaorecommendsimprovementsprogramphrma
https://phrma.org/blog/author/randy-burkholder
randyburkholderphrma
https://phrma.org/resources/chart-pack-biopharmaceuticals-in-perspective-summer-2019
chart packbiopharmaceuticalsperspectivesummerphrma
https://phrma.org/resources/bio_phrma-principles-on-responsible-sharing-of-truthful-and-non_misleading-cod15
responsiblesharinginformationmedicinesphrma
https://phrma.org/blog/combatting-a-lack-of-transparency-in-health-insurance-exchanges
health insurance exchangeslacktransparencyphrma
https://phrma.org/blog/ask-about-adherence-qanda-with-dr-helaine-resnick-on-diabetes-care
askadherenceqdrhelaine
https://phrma.org/resources/phrma-statement-on-the-2024-us-election
phrmastatementuelection
https://phrma.org/blog/new-report-finds-rampant-abuse-of-the-340b-program
new reportfindsrampantabuseprogram
https://phrma.org/blog/medicare-monday-upcoming-on-the-medicare-calendar
medicaremondayupcomingcalendarphrma
https://phrma.org/resources/phrma-comments-ustr-on-the-us-eu-trade-and-technology-council-global-trade-challenges-working-group
eu tradephrmacommentsustr
https://phrma.org/blog/how-innovative-medicines-are-benefiting-countries-across-the-globe
innovative medicinesbenefitingcountriesacrossglobe
https://phrma.org/blog/the-reality-of-prescription-drug-spending-in-medicaid
prescription drugrealityspendingmedicaidphrma
https://phrma.org/blog/guest-post-securing-the-health-care-supply-chain-during-covid-19
guest posthealth caresupply chainsecuringcovid
https://phrma.org/blog/icymi-report-highlights-overall-decrease-in-cancer-death-rates
report highlightsdeath ratesicymioveralldecrease
https://www.campaignasia.com/article/phrma-pushes-to-penetrate-japan-market/lxayfkcuo6cdgrs7v53v8k29bq
campaign asiaphrmapushespenetratejapan
https://phrma.org/resources/the-future-of-fighting-cancer
fighting cancerfuturephrma
https://phrma.org/blog/icymi-the-opaque-industry-secretly-inflating-prices-for-prescription-drugs
prescription drugsicymiopaqueindustrysecretly
https://phrma.org/
phrma
https://phrma.org/blog/the-biden-administration-has-failed-to-advance-an-inclusive-worker-centered-trade-agenda
biden administrationfailedadvanceinclusiveworker
https://phrma.org/blog/supporting-opportunities-for-enhanced-competition-in-the-marketplace
supportingopportunitiesenhancedcompetitionmarketplace
https://phrma.org/resources/pediatric-drug-development-issue-brief-progress-in-a-critical-but-challenging-space
drug developmentissue briefpediatricprogresscritical
https://phrma.org/resources/phrma-letter-to-hrsa-and-hhs-regarding-duplicate-discounting-in-340b
phrmaletterhrsahhsregarding
https://phrma.org/blog/phrma-and-bio-citizen-petition-to-fda-calls-for-biosimilar-labeling-guidance
citizen petitionphrmabiofdacalls
https://phrma.org/resources/phrma-principles-on-interactions-with-patient-organizations
patient organizationsphrmaprinciplesinteractions
https://phrma.org/blog/a-conversation-with-barry-greene-ceo-of-sage-therapeutics
conversationbarrygreeneceosage
https://phrma.org/blog/new-report-part-b-proposal-is-more-aggressive-than-previous-efforts
new reportpart bproposalaggressiveprevious
https://phrma.org/resources/340b-the-hospital-markup-program
hospitalmarkupprogramphrma
https://www.ajmc.com/view/phrma-takes-aim-at-ipab-a-longtime-target
Lawmakers from both parties have expressed their dislike for an entity that could take away their spending authority. But a leading Democrat also raised the...
phrmatakesaimipablongtime
https://phrma.org/blog/340b-spotlight-new-report-raises-questions-about-eligibility-metric-for-340b-hospitals
new reportspotlightraisesquestionseligibility
https://phrma.org/resources/patient-experience-survey-barriers-to-health-care-access-in-the-patient-experience
patient experience surveyhealth care accessbarriers
https://phrma.org/resources/research-in-colorado
researchcoloradophrma
https://phrma.org/blog/dose-sharing-as-a-part-of-the-covid-19-global-vaccine-equity-strategy
dosesharingpartcovidglobal
https://phrma.org/blog/medicare-monday-adherence-in-medicare-and-medicaid-saves-money
medicaremondayadherencemedicaidsaves
https://phrma.org/resources/list-of-medicines-in-development-for-vaccines-2017
listmedicinesdevelopmentvaccinesphrma
https://www.washingtonblade.com/tag/phrma/
America's Leading LGBT News Source
washington bladelgbtq newsphrmaarchivespolitics
https://phrma.org/blog/icymi-physicians-want-better-information-sharing-with-biopharmaceutical-companies
information sharingbiopharmaceutical companiesicymiphysicianswant
https://phrma.org/blog/medicare-monday-negotiation-in-medicare-part-d-works
medicaremondaynegotiationpartworks
https://phrma.org/blog/4-things-to-know-about-biopharmaceutical-efforts-to-fight-cancer
fight cancerthingsknowbiopharmaceuticalefforts
https://phrma.org/blog/tearing-down-barriers-to-cooperation-with-strengthened-intellectual-property-protections
intellectual propertytearingbarrierscooperationstrengthened
https://phrma.org/blog/science-of-hope-incorporating-the-patient-perspective
patient perspectivesciencehopephrma
https://phrma.org/resources/phrma-special-301-submission-2026
phrmaspecialsubmission
https://phrma.org/blog/medicare-monday-a-closer-look-at-part-b-spending
closer lookpart bmedicaremondayspending
https://phrma.org/resources/phrma-statement-on-ipay-2028-selected-drug-list
drug listphrmastatementipayselected
https://phrma.org/resources/hospital-practices-increase-costs-of-medicines-for-patients-and-employers-new-report-shows
hospitalpracticesincreasecostsmedicines
https://phrma.org/resources/the-value-collaborative
policy portalvaluecollaborativephrma
https://phrma.org/blog/sharing-rebates-can-save-americans-with-diabetes-500-each-year-and-improve-adherence-especially-for-black-and-hispanic-americans
sharingrebatessaveamericansdiabetes
https://phrma.org/resources/moran-company-study-on-hospital-charges-and-reimbursement-for-medicines
moran companyhospital chargesstudyreimbursementmedicines
https://phrma.org/blog/new-report-highlights-impact-of-intellectual-property-on-u-s-economy
new reportintellectual propertyhighlightsimpact
https://phrma.org/blog/what-scientific-experts-are-saying-about-vaccine-safety
scientific expertsvaccine safetysayingphrma
https://phrma.org/blog/new-report-vaccines-continue-to-drive-improved-health-outcomes
new reportimproved healthvaccinescontinuedrive
https://phrma.org/blog/event-new-era-of-medicine-comes-to-capitol-hill
new eracapitol hilleventmedicinecomes
https://phrma.org/resources/medicines-in-development-for-parkinsons-disease-2014-report
medicinesdevelopmentparkinsondiseasereport
https://phrma.org/blog/frazier-phrma-scholarship-awarded-to-four-college-bound-students-in-philadelphia-and-dc
college boundfrazierphrmascholarshipawarded
https://phrma.org/resources/state-map/pennsylvania
pennsylvaniaphrma
https://phrma.org/blog/new-polling-shows-americans-are-sounding-the-alarm-on-the-trips-ip-waiver
new pollingshowsamericanssoundingalarm
https://phrma.org/blog/manufacturing-u-s-jobs-and-breakthroughs
manufacturingjobsbreakthroughsphrma
https://phrma.org/blog/patient-priorities-in-the-2024-election
patient prioritieselectionphrma
https://phrma.org/resources/phrma-comments-to-the-2021-national-trade-estimate-report
phrmacommentsnationaltradeestimate
https://www.techtarget.com/revcyclemanagement/news/366602070/PhrMA-340B-Hospitals-Reimbursed-3X-the-Amount-Paid-for-Drugs
New Analysis shows 340B hospitals are reimbursed three times more on average for physician-administered brand medications under the drug pricing program.
phrmahospitalsamountpaiddrugs
https://phrma.org/blog/new-analysis-finds-340b-hospitals-push-patients-toward-costly-care-to-boost-profits
newanalysisfindshospitalspush
https://phrma.org/resources/implications-of-the-drug-pricing-provisions-in-reconciliation
drug pricingimplicationsprovisionsreconciliationphrma
https://phrma.org/blog/putting-the-cost-of-medicines-in-context
puttingcostmedicinescontextphrma
https://phrma.org/blog/new-white-paper-recognizing-emerging-value-in-oncology-treatments
new white paperrecognizingemergingvalueoncology
https://phrma.org/blog/what-is-the-low-income-subsidy-program-how-is-it-changing
low incomesubsidy program